15.10.2015 Views

Global Hernia Clinical Trials Review Market Share, Size & Trend 2015 radiant Insights, Inc

Summary GlobalData's clinical trial report,Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process. Read Complete Report with TOC @ http://www.radiantinsights.com/research/hernia-global-clinical-trials-review-h1-2015 The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage. Scope - The report provides a snapshot of the global clinical trials landscape - Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status - The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company - The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment - The Report provides enrollment trends for the past five years - Report provides latest news for the past three months Reasons to buy - Assists in formulating key business strategies with regards to investment - Helps in identifying prominent locations for conducting clinical trials which saves time and cost - Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities - Supports understanding of trials count and enrollment trends by country in global therapeutics market - Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials - Facilitates clinical trial assessment of the indication on a global, regional and country level

Summary

GlobalData's clinical trial report,Hernia Global Clinical Trials Review, H1, 2015" provides an overview of Hernia clinical trials scenario. This report provides top line data relating to the clinical trials on Hernia. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). Global Data Clinical Trial Reports are generated using Global Data's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

Read Complete Report with TOC @ http://www.radiantinsights.com/research/hernia-global-clinical-trials-review-h1-2015

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Scope

- The report provides a snapshot of the global clinical trials landscape

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

- The Report provides enrollment trends for the past five years

- Report provides latest news for the past three months

Reasons to buy

- Assists in formulating key business strategies with regards to investment

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost

- Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

- Supports understanding of trials count and enrollment trends by country in global therapeutics market

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

- Facilitates clinical trial assessment of the indication on a global, regional and country level

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

<strong>Global</strong> <strong>Hernia</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong> <strong>Market</strong> <strong>Share</strong>, <strong>Size</strong> & <strong>Trend</strong><br />

<strong>2015</strong>: Radiant <strong>Insights</strong>, <strong>Inc</strong><br />

Summary<br />

<strong>Global</strong>Data's clinical trial report,<strong>Hernia</strong> <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Review</strong>, H1, <strong>2015</strong>" provides an overview<br />

of <strong>Hernia</strong> clinical trials scenario. This report provides top line data relating to the clinical trials on <strong>Hernia</strong>.<br />

Report includes an overview of trial numbers and their average enrollment in top countries conducted<br />

across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase,<br />

trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials<br />

(based on number of ongoing trials). <strong>Global</strong> Data <strong>Clinical</strong> Trial Reports are generated using <strong>Global</strong> Data's<br />

proprietary database - Pharma eTrack <strong>Clinical</strong> trials database. <strong>Clinical</strong> trials are collated from 80+<br />

different clinical trial registries, conferences, journals, news etc across the globe. <strong>Clinical</strong> trials database<br />

undergoes periodic update by dynamic process.<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

The report enhances the decision making capabilities and helps to create an effective counter strategies to<br />

gain competitive advantage.<br />

Scope<br />

- The report provides a snapshot of the global clinical trials landscape<br />

- Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status,<br />

Trial Phase, Sponsor Type and End point status<br />

- The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining<br />

to the company<br />

- The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason<br />

for unaccomplishment<br />

- The Report provides enrollment trends for the past five years<br />

- Report provides latest news for the past three months<br />

Reasons to buy<br />

- Assists in formulating key business strategies with regards to investment<br />

- Helps in identifying prominent locations for conducting clinical trials which saves time and cost


- Provides top level analysis of <strong>Global</strong> <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong> which helps in identifying key business<br />

opportunities<br />

- Supports understanding of trials count and enrollment trends by country in global therapeutics market<br />

- Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed<br />

and uncompleted (terminated, suspended or withdrawn) trials<br />

- Facilitates clinical trial assessment of the indication on a global, regional and country level<br />

Table of Contents<br />

Table of Contents 2<br />

List of Tables 4<br />

List of Figures 5<br />

Introduction 6<br />

<strong>Hernia</strong> 6<br />

Report Guidance 6<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Clinical</strong> <strong>Trials</strong> by Region 7<br />

<strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Country 8<br />

Top Five Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Asia-Pacific 10<br />

Top Five Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Europe 11<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in North America 12<br />

Top Countries Contributing to <strong>Clinical</strong> <strong>Trials</strong> in Middle East and Africa 13<br />

<strong>Clinical</strong> <strong>Trials</strong> by G7 Countries: Proportion of <strong>Hernia</strong> to Genito Urinary System And Sex Hormones<br />

<strong>Clinical</strong> <strong>Trials</strong> 14<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase in G7 Countries 15<br />

<strong>Clinical</strong> <strong>Trials</strong> in G7 Countries by Trial Status 16<br />

<strong>Clinical</strong> <strong>Trials</strong> by E7 Countries: Proportion of <strong>Hernia</strong> to Genito Urinary System And Sex Hormones<br />

<strong>Clinical</strong> <strong>Trials</strong> 17


<strong>Clinical</strong> <strong>Trials</strong> by Phase in E7 Countries 18<br />

<strong>Clinical</strong> <strong>Trials</strong> in E7 Countries by Trial Status 19<br />

<strong>Clinical</strong> <strong>Trials</strong> by Phase 20<br />

In Progress <strong>Trials</strong> by Phase 21<br />

<strong>Clinical</strong> <strong>Trials</strong> by Trial Status 22<br />

<strong>Clinical</strong> <strong>Trials</strong> by End Point Status 23<br />

Unaccomplished <strong>Trials</strong> of <strong>Hernia</strong> 24<br />

Subjects Recruited Over a Period of Time 26<br />

<strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type 27<br />

Prominent Sponsors 28<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Top Companies Participating in <strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> 29<br />

Prominent Drugs 30<br />

<strong>Clinical</strong> Trial Profiles 31<br />

<strong>Clinical</strong> Trial Overview of Top Companies 31<br />

Seikagaku Corporation 31<br />

<strong>Clinical</strong> Trial Overview of Seikagaku Corporation 31<br />

Pacira Pharmaceuticals, <strong>Inc</strong>. 32<br />

<strong>Clinical</strong> Trial Overview of Pacira Pharmaceuticals, <strong>Inc</strong>. 32<br />

ZonMw 33<br />

<strong>Clinical</strong> Trial Overview of ZonMw 33<br />

Premier Research Group Limited 34<br />

<strong>Clinical</strong> Trial Overview of Premier Research Group Limited 34<br />

Physicians' Services <strong>Inc</strong>orporated Foundation 35<br />

<strong>Clinical</strong> Trial Overview of Physicians' Services <strong>Inc</strong>orporated Foundation 35


Johnson & Johnson 36<br />

<strong>Clinical</strong> Trial Overview of Johnson & Johnson 36<br />

Innocoll AG 37<br />

<strong>Clinical</strong> Trial Overview of Innocoll AG 37<br />

Baxter International <strong>Inc</strong>. 38<br />

<strong>Clinical</strong> Trial Overview of Baxter International <strong>Inc</strong>. 38<br />

Children's Anesthesiology Associates, Ltd. 39<br />

<strong>Clinical</strong> Trial Overview of Children's Anesthesiology Associates, Ltd. 39<br />

AstraZeneca Plc 40<br />

<strong>Clinical</strong> Trial Overview of AstraZeneca Plc 40<br />

<strong>Clinical</strong> Trial Overview of Top Institutes / Government 41<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Erasmus MC 41<br />

<strong>Clinical</strong> Trial Overview of Erasmus MC 41<br />

All India Institute of Medical Sciences 42<br />

<strong>Clinical</strong> Trial Overview of All India Institute of Medical Sciences 42<br />

Diskapi Teaching and Research Hospital 43<br />

<strong>Clinical</strong> Trial Overview of Diskapi Teaching and Research Hospital 43<br />

Ghent University Hospital 44<br />

<strong>Clinical</strong> Trial Overview of Ghent University Hospital 44<br />

Karolinska Institute 45<br />

<strong>Clinical</strong> Trial Overview of Karolinska Institute 45<br />

Mansoura University 46<br />

<strong>Clinical</strong> Trial Overview of Mansoura University 46<br />

Mayo Clinic 47


<strong>Clinical</strong> Trial Overview of Mayo Clinic 47<br />

NHS Trusts <strong>Clinical</strong> <strong>Trials</strong> 48<br />

<strong>Clinical</strong> Trial Overview of NHS Trusts <strong>Clinical</strong> <strong>Trials</strong> 48<br />

Tabriz University of Medical Sciences 49<br />

<strong>Clinical</strong> Trial Overview of Tabriz University of Medical Sciences 49<br />

Ahvaz Jundishapur University of Medical Sciences 50<br />

<strong>Clinical</strong> Trial Overview of Ahvaz Jundishapur University of Medical Sciences 50<br />

Five Key <strong>Clinical</strong> Profiles 51<br />

Appendix 78<br />

Abbreviations 78<br />

Definitions 78<br />

Research Methodology 79<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

Secondary Research 79<br />

About <strong>Global</strong>Data 80<br />

Contact Us 80<br />

Disclaimer 80<br />

Source 81<br />

List of Tables<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region, <strong>2015</strong>* 7<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries, <strong>2015</strong>* 10<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries, <strong>2015</strong>* 11


<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries, <strong>2015</strong>* 12<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries, <strong>2015</strong>* 13<br />

Proportion of <strong>Hernia</strong> to Genito Urinary System And Sex Hormones <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%),<br />

<strong>2015</strong>* 14<br />

<strong>Hernia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 15<br />

<strong>Hernia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 16<br />

Proportion of <strong>Hernia</strong> to Genito Urinary System And Sex Hormones <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%),<br />

<strong>2015</strong>* 17<br />

<strong>Hernia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 18<br />

<strong>Hernia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 19<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 20<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase <strong>2015</strong>* 21<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 22<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 23<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, Suspended <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 24<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, Terminated <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>* 25<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014 26<br />

<strong>Hernia</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type, <strong>2015</strong>* 27<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 28<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 29<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 30<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Seikagaku Corporation, <strong>2015</strong>* 31<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Pacira Pharmaceuticals, <strong>Inc</strong>.,<br />

<strong>2015</strong>* 32<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by ZonMw, <strong>2015</strong>* 33


<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Premier Research Group Limited,<br />

<strong>2015</strong>* 34<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Physicians' Services <strong>Inc</strong>orporated<br />

Foundation, <strong>2015</strong>* 35<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Johnson & Johnson, <strong>2015</strong>* 36<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Innocoll AG, <strong>2015</strong>* 37<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Baxter International <strong>Inc</strong>., <strong>2015</strong>* 38<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Children's Anesthesiology<br />

Associates, Ltd., <strong>2015</strong>* 39<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by AstraZeneca Plc, <strong>2015</strong>* 40<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Erasmus MC, <strong>2015</strong>* 41<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by All India Institute of Medical<br />

Sciences, <strong>2015</strong>* 42<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Diskapi Teaching and Research<br />

Hospital, <strong>2015</strong>* 43<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Ghent University Hospital, <strong>2015</strong>*<br />

44<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Karolinska Institute, <strong>2015</strong>* 45<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Mansoura University, <strong>2015</strong>* 46<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Mayo Clinic, <strong>2015</strong>* 47<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by NHS Trusts <strong>Clinical</strong> <strong>Trials</strong>, <strong>2015</strong>*<br />

48<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Tabriz University of Medical<br />

Sciences, <strong>2015</strong>* 49<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong> <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Ahvaz Jundishapur University of<br />

Medical Sciences, <strong>2015</strong>* 50<br />

List of Figures


<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Region (%), <strong>2015</strong>* 7<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> and Average Enrollment by Top Countries, <strong>2015</strong>* 8<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Top Countries, <strong>2015</strong>* 9<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Asia-Pacific, Top Five Countries (%), <strong>2015</strong>* 10<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Europe, Top Five Countries (%), <strong>2015</strong>* 11<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, North America, Top Countries (%), <strong>2015</strong>* 12<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, Middle East and Africa, Top Countries (%), <strong>2015</strong>* 13<br />

Proportion of <strong>Hernia</strong> to Genito Urinary System And Sex Hormones <strong>Clinical</strong> <strong>Trials</strong>, G7 Countries (%),<br />

<strong>2015</strong>* 14<br />

<strong>Hernia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 15<br />

Read Complete Report with TOC @ http://www.<strong>radiant</strong>insights.com/research/hernia-globalclinical-trials-review-h1-<strong>2015</strong><br />

<strong>Hernia</strong> Therapeutics, G7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 16<br />

Proportion of <strong>Hernia</strong> to Genito Urinary System And Sex Hormones <strong>Clinical</strong> <strong>Trials</strong>, E7 Countries (%),<br />

<strong>2015</strong>* 17<br />

<strong>Hernia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Phase, <strong>2015</strong>* 18<br />

<strong>Hernia</strong> Therapeutics, E7 Countries, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 19<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Phase (%), <strong>2015</strong>* 20<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> In Progress by Phase, <strong>2015</strong>* 21<br />

<strong>Hernia</strong> Therapeutics, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Trial Status, <strong>2015</strong>* 22<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, by End Point Status, <strong>2015</strong>* 23<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Average Enrollment Target <strong>Trend</strong>s, 2010-2014 26<br />

<strong>Hernia</strong> Therapeutics <strong>Market</strong>, <strong>Global</strong>, <strong>Clinical</strong> <strong>Trials</strong> by Sponsor Type (%), <strong>2015</strong>* 27<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Key Sponsors, <strong>2015</strong>* 28<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Top Companies by Phase, <strong>2015</strong>* 29<br />

<strong>Hernia</strong> Therapeutics <strong>Clinical</strong> <strong>Trials</strong>, <strong>Global</strong>, Ongoing <strong>Clinical</strong> <strong>Trials</strong> by Prominent Drugs, <strong>2015</strong>* 30<br />

<strong>Global</strong>Data Methodology 79


About Radiant <strong>Insights</strong><br />

Radiant <strong>Insights</strong> is a platform for companies looking to meet their market research and business<br />

intelligence requirements. We assist and facilitate organizations and individuals procure market research<br />

reports, helping them in the decision making process. We have a comprehensive collection of reports,<br />

covering over 40 key industries and a host of micro markets. In addition to over extensive database of<br />

reports, our experienced research coordinators also offer a host of ancillary services such as, research<br />

partnerships/ tie-ups and customized research solutions.<br />

For More Information, Visit Radiant <strong>Insights</strong><br />

Contact:<br />

Michelle Thoras<br />

Corporate Sales Specialist, USA<br />

Radiant <strong>Insights</strong>, <strong>Inc</strong><br />

Phone: 1-415-349-0054<br />

Toll Free: 1-888-202-9519<br />

Email: sales@<strong>radiant</strong>insights.com<br />

Blog URL: http://www.<strong>radiant</strong>insightsinc.blogspot.com

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!